IL6 and obesity disorder: Chronic systemic inflammation with persistently elevated IL-6, as seen in metabolic syndrome and obesity, can, over time, lead to diffuse myocardial fibrosis and heart failure with preserved ejection fraction through its profibrotic and prohypertrophic effects [67].